Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure

JACC: Cardiovascular Interventions

Volumn 9, Issue 12, 2016, Pages 1259-1265

  Negi, Smita I ^a   Torguson, Rebecca ^a   Gai, Jiaxiang ^a   Kiramijyan, Sarkis ^a   Koifman, Edward ^a   Chan, Rosanna ^a   Randolph, Pamela ^a   Pichard, Augusto ^a   Satler, Lowell F ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

brachytherapy; drug eluting stent(s); in stent restenosis

Indexed keywords

AGED; ARTERY LESION; ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; DEVICE FAILURE; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; INTRAVASCULAR BRACHYTHERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS; ADVERSE EFFECTS; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DEVICES; DIAGNOSTIC IMAGING; DISTRICT OF COLUMBIA; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS COMPLICATION; RADIATION RESPONSE; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; BRACHYTHERAPY; CORONARY RESTENOSIS; CORONARY VESSELS; DISTRICT OF COLUMBIA; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS FAILURE; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84993967684     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.03.018     Document Type: Article

References (27)

1. 1 Murices, M.C., Serruys, P.W., Sousa, J.E., et al. Randomized study with sirolimus-coated Bx velocity balloon-expandable stent in treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002), 1773–1780.
2. 2 Daemen, J., Wenaweser, P., Tsuchida, K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007), 667–678.
3. 3 Spaulding, C., Daemen, J., Boersma, E., et al. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007), 989–997.
4. 4 Ahmed, M.J., Mint, G.S., Waksman, R., et al. Serial intravascular ultrasound assessment of efficacy of intracoronary gamma radiation therapy for preventing recurrence in very long, diffuse, in-stent restenosis lesions. Circulation 104 (2001), 856–859.
5. 5 Lemos, P.A., Serruys, P.W., van Domburg, R.T., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004), 190–195.
6. 6 Mercado, N., Boersma, E., Wijns, W., et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 38 (2001), 645–652.
7. 7 Rittger, H., Waliszewski, M., Brachmann, J., et al. Long-term outcomes after treatment With a paclitaxel coated balloon versus balloon angioplasty: insights from PEPCAD-DES (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent® Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter). J Am Coll Cardiol Intv 59 (2012), 1377–1382.
8. 8 Turco, M.A., Ormiston, J.A., Popma, J.J., et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with new thin-strut TAXUS Liberte stent: 1-year results from TAXUS ATLAS program. J Am Coll Cardiol Intv 1 (2008), 699–709.
9. 9 Costa, M., Angiolillo, D.J., Teirstein, P., et al. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry. J Invasive Cardiol 17 (2005), 396–398.
10. 10 Schofer, J., Schluter, M., Gershlick, A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial. Lancet 362 (2003), 1093–1099.
11. 11 Stone, G.W., Ellis, S.G., Cox, D.A., et al. One-year clinical results with slow-release, polymer-based, paclitaxel-eluting TAXUS stent. Circulation 109 (2004), 1942–1947.
12. 12 Waksman, R., Bhargava, B., Chan, R.C., et al. Intracoronary radiation with gamma wire inhibit recurrent in-stent restenosis. Cardiovasc Radiat Med 2 (2001), 63–68.
13. 13 Teirstein, P.S., Masullo, V., Jani, S., et al. Two year follow up after catheter based radiotherapy to inhibit coronary restenosis. Circulation 99 (1999), 243–247.
14. 14 Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
15. 15 Cutlip, D.E., Windecker, S., Mehran, R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007), 2344–2351.
16. 16 Kim, S.W., Mintz, G.S., Escolar, E., et al. An intravascular ultrasound analysis of mechanisms of restenosis comparing drug-eluting stents with brachytherapy. Am J Cardiol 97 (2006), 1292–1298.
17. 17 Waksman, R., Rodriguez, J.C., Robinson, K.A., et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 96 (1997), 1944–1952.
18. 18 Kuchulakanti, P., Torguson, R., Canos, D., et al. Optimizing dosimetry with high dose intracoronary gamma radiation for patients with diffuse in stent restenosis. Cardiovasc Revasc Med 6 (2005), 108–112.
19. 19 Stone, G.W., Ellis, S.G., O'Shaughnessy, C.D., et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents. JAMA 295 (2006), 1253–1263.
20. 20 Holmes, D.R. Jr., Teirstein, P., Satler, L., et al., on behalf of the SISR Investigators. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents. JAMA 295 (2006), 1264–1273.
21. 21 Torguson, R., Abate, M., Deible, R., et al. Intravascular brachytherapy versus drug-eluting stents for treatment of patients with drug-eluting stent restenosis. Am J Cardiol 98 (2006), 1340–1344.
22. 22 Garg, S., Smith, K., Torguson, R., et al. Treatment of drug-eluting stent restenosis with same versus different drug-eluting stent. Catheter Cardiovasc Interv 70 (2007), 9–14.
23. 23 Mehilli, J., Byrne, R.A., Tiroch, et al. Randomized trial of paclitaxel versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents. J Am Coll Cardiol 55 (2010), 2710–2716.
24. 24 Maluenda, G., BenDor, I., Gaglia, M.A., et al. Clinical outcomes and treatment after drug-eluting stent failure. Circ Cardiovasc Interv 5 (2012), 12–19.
25. 25 Waksman, R., Bhargava, B., Mintz, G.S., et al. Late total occlusion after intracoronary brachytherapy for patients with in stent restenosis. J Am Coll Cardiol 36 (2000), 65–68.
26. 26 Ajani, A.E., Waksman, R., Sharma, A.K., et al. Three year follow up after intracoronary gamma radiation therapy for in-stent restenosis. Original WRIST. Washington Radiation for In-stent restenosis trial. Cardiovasc Radiat Med 2 (2001), 200–204.
27. 27 Limpijankit, T., Mehran, R., Mintz, G.S., et al. Long term follow up of patients after gamma intracoronary brachytherapy failure. Am J Cardiol 92 (2003), 315–318.